Advertisement

ASO Author Reflections: Optimizing the Outcomes for Patients: The Evolution of the Management of Regional Disease in Patients with Melanoma

  • Michael C. Lowe
  • Clara R. Farley
  • Keith A. Delman
ASO Author Reflections
  • 18 Downloads

Notes

Disclosure

Michael C. Lowe, Clara R. Farley, and Keith A. Delman have no conflict of interest to disclose.

References

  1. 1.
    Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307–17.CrossRefGoogle Scholar
  2. 2.
    Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376:2211–22.CrossRefGoogle Scholar
  3. 3.
    Faries MB, Thompson JF, Cochran AJ, et al. The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the multicenter selective lymphadenectomy trial I. Ann Surg Oncol. 2010;17(12):3324–9.CrossRefGoogle Scholar
  4. 4.
    Postlewait LM, Farley CR, Seamens AM, et al. Morbidity and outcomes following axillary lymphadenectomy for melanoma: weighing the risk of surgery in the era of MSLT-II. Ann Surg Oncol. 2018;25:465–70.CrossRefGoogle Scholar
  5. 5.
    Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–75.CrossRefGoogle Scholar
  6. 6.
    Kimbrough CW, Egger ME, McMasters KM, et al. Molecular staging of sentinel lymph nodes identifies melanoma patients at increased risk of nodal recurrence. J Am Coll Surg. 2016;222(4):357–63.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  • Michael C. Lowe
    • 1
  • Clara R. Farley
    • 1
  • Keith A. Delman
    • 1
  1. 1.Division of Surgical Oncology, Department of SurgeryWinship Cancer Institute, Emory UniversityAtlantaUSA

Personalised recommendations